Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 117

Results For "disease"

2672 News Found

Ayush and Tribal Affairs Ministries announce joint initiative on public health of tribal students
Policy | February 22, 2024

Ayush and Tribal Affairs Ministries announce joint initiative on public health of tribal students

We are achieving the target of developed India by making our young children healthy today


Ayush Ministry to launch project of health screening and management through ayurvedic interventions
News | February 21, 2024

Ayush Ministry to launch project of health screening and management through ayurvedic interventions

The project aims at screening the general health condition of the students enrolled in classes 6th to 12th.


Mandaviya inaugurates Vivekananda Cancer & Super Speciality Extension Hospital in Latur
News | February 21, 2024

Mandaviya inaugurates Vivekananda Cancer & Super Speciality Extension Hospital in Latur

The preventive and promotive approach of our traditional health care systems has played a significant role in modern age today


AstraZeneca completes acquisition of Icosavax
News | February 21, 2024

AstraZeneca completes acquisition of Icosavax

The acquisition will build on AstraZeneca’s expertise in respiratory syncytial virus


GSK completes acquisition of Aiolos Bio
News | February 19, 2024

GSK completes acquisition of Aiolos Bio

The acquisition of Aiolos includes AIO-001, a potentially best-in-class, long-acting antithymic stromal lymphopoietin (TSLP) monoclonal antibody


Zydus receives USFDA approval for Isosorbide Mononitrate Extended-Release, Tablets USP
Drug Approval | February 17, 2024

Zydus receives USFDA approval for Isosorbide Mononitrate Extended-Release, Tablets USP

Isosorbide mononitrate is used to prevent chest pain (angina) in patients with a certain heart condition (coronary artery disease)


YS Biopharma appoints new Directors
People | February 17, 2024

YS Biopharma appoints new Directors

The Board has elected Dr. Ajit Shetty, who had served as the Company's Interim Chairperson of the Board since December 9, 2023, as Chairperson of the Board, effective February 13, 2024


UBE announces Phase I clinical trial for SSAO/VAP-1 licensed exclusively to Novo Nordisk
Clinical Trials | February 15, 2024

UBE announces Phase I clinical trial for SSAO/VAP-1 licensed exclusively to Novo Nordisk

MASH is a chronic and progressive liver disease characterised by fat accumulation and inflammation in the liver,


Medanta launches monthly talk show around cardiac care - 'Heart 2 Heart'
Healthcare | February 15, 2024

Medanta launches monthly talk show around cardiac care - 'Heart 2 Heart'

The talk show will be held monthly via Medanta's YouTube, Facebook and LinkedIn channe


Ascentage Pharma’s Phase III study of Olverembatinib cleared by FDA
Drug Approval | February 14, 2024

Ascentage Pharma’s Phase III study of Olverembatinib cleared by FDA

The US FDA's clearance of the trial marks the first global registrational Phase III trial for olverembatinib in patients with CP-CML to be conducted.